Income Statement (TTM)
RedHill Biopharma Ltd. - Depositary Receipt (Common Stock) Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 44 | 64 | 84 | 84 | 85 | 86 | 78 | 75 | 71 | 62 | 52 | 36 | 19 | 7 | 4 | 4 | 6 | 8 | 9 | 10 |
| Change (%) | 44.67 | 30.33 | 0.72 | 0.79 | 0.72 | -8.71 | -4.03 | -5.40 | -13.05 | -15.38 | -31.65 | -47.52 | -65.19 | -35.42 | -12.09 | 58.48 | 36.90 | 9.37 | 8.57 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 26 | 37 | 45 | 41 | 41 | 49 | 37 | 35 | 35 | 33 | 29 | 20 | 12 | 3 | 3 | 2 | 3 | 3 | 3 | 3 |
| Change (%) | 40.66 | 20.97 | -8.06 | -0.75 | 21.32 | -26.03 | -4.36 | 0.64 | -5.22 | -14.04 | -28.58 | -43.63 | -70.02 | -26.31 | -4.08 | 15.28 | 13.25 | 3.18 | 3.08 | |
| % of Revenue | 58.96 | 57.32 | 53.21 | 48.57 | 47.83 | 57.61 | 46.68 | 46.52 | 49.49 | 53.94 | 54.80 | 57.26 | 61.49 | 52.97 | 60.45 | 65.96 | 47.97 | 39.69 | 37.44 | 35.55 |
| Gross Operating Profit | 18 | 27 | 39 | 43 | 44 | 36 | 42 | 40 | 36 | 28 | 24 | 15 | 7 | 3 | 2 | 1 | 3 | 5 | 6 | 6 |
| Change (%) | 50.42 | 42.89 | 10.70 | 2.24 | -18.17 | 14.82 | -3.74 | -10.65 | -20.72 | -16.95 | -35.37 | -52.72 | -57.49 | -45.69 | -24.34 | 142.19 | 58.71 | 13.44 | 11.85 | |
| % of Revenue | 41.04 | 42.68 | 46.79 | 51.43 | 52.17 | 42.39 | 53.32 | 53.48 | 50.51 | 46.06 | 45.20 | 42.74 | 38.51 | 47.03 | 39.55 | 34.04 | 52.03 | 60.31 | 62.56 | 64.45 |
| SG&A | 61 | 75 | 82 | 92 | 95 | 88 | 87 | 79 | 69 | 64 | 55 | 46 | 38 | 31 | 25 | 21 | 18 | 16 | 14 | 12 |
| Change (%) | 23.16 | 9.91 | 11.54 | 3.51 | -7.13 | -0.70 | -9.65 | -13.13 | -6.64 | -14.79 | -16.46 | -16.66 | -18.46 | -20.75 | -14.59 | -12.99 | -14.93 | -9.90 | -10.98 | |
| % of Revenue | 136.27 | 116.01 | 97.83 | 108.35 | 111.28 | 102.60 | 111.61 | 105.08 | 96.49 | 103.61 | 104.33 | 127.51 | 202.48 | 474.35 | 582.08 | 565.55 | 310.49 | 192.93 | 158.94 | 130.32 |
| R&D | 13 | 16 | 21 | 28 | 30 | 29 | 25 | 16 | 12 | 7 | 5 | 5 | 4 | 4 | 3 | 2 | 2 | 2 | 2 | 2 |
| Change (%) | 31.11 | 28.62 | 33.54 | 5.28 | -1.08 | -14.99 | -35.32 | -25.93 | -39.41 | -27.17 | -4.24 | -19.97 | -13.16 | -21.39 | -33.08 | -7.22 | -7.78 | 9.60 | 8.76 | |
| % of Revenue | 28.27 | 25.62 | 25.29 | 33.53 | 35.02 | 34.40 | 32.03 | 21.59 | 16.90 | 11.78 | 10.14 | 14.20 | 21.65 | 54.03 | 65.77 | 50.07 | 29.31 | 19.74 | 19.79 | 19.82 |
| OpEx | 99 | 128 | 148 | 161 | 165 | 167 | 149 | 130 | 116 | 105 | 85 | 64 | 46 | 29 | 25 | 24 | 22 | 20 | 19 | 18 |
| Change (%) | 28.78 | 15.51 | 8.78 | 2.74 | 0.97 | -10.72 | -12.67 | -11.03 | -9.61 | -18.84 | -25.08 | -28.40 | -35.47 | -15.34 | -2.79 | -8.06 | -8.76 | -6.31 | -6.74 | |
| % of Revenue | 223.49 | 198.95 | 176.33 | 190.44 | 194.12 | 194.61 | 190.33 | 173.19 | 162.89 | 169.33 | 162.41 | 178.01 | 242.83 | 450.20 | 590.21 | 652.68 | 378.66 | 252.36 | 216.17 | 185.70 |
| Operating Income | -55 | -64 | -64 | -76 | -80 | -81 | -71 | -55 | -45 | -43 | -33 | -28 | -27 | -23 | -21 | -20 | -16 | -12 | -10 | -8 |
| Change (%) | 15.92 | 0.53 | 19.35 | 4.89 | 1.24 | -12.85 | -22.24 | -18.71 | -4.14 | -23.83 | -14.56 | -3.90 | -14.66 | -9.60 | -0.89 | -20.09 | -25.15 | -16.61 | -19.91 | |
| % of Revenue | -123.49 | -98.95 | -76.33 | -90.44 | -94.12 | -94.61 | -90.33 | -73.19 | -62.89 | -69.33 | -62.41 | -78.01 | -142.83 | -350.20 | -490.21 | -552.68 | -278.66 | -152.36 | -116.17 | -85.70 |
| Interest Expense | -9 | -12 | -17 | -18 | -17 | -17 | -16 | -16 | -38 | -41 | -38 | -36 | -13 | -0 | -22 | -0 | ||||
| Change (%) | 44.15 | 35.33 | 4.06 | -1.08 | -4.47 | -5.09 | -0.06 | 144.22 | 7.71 | -8.44 | -6.05 | -64.61 | -97.08 | 5,978.47 | ||||||
| % of Revenue | -19.41 | -19.34 | -20.09 | -20.75 | -20.37 | -19.32 | -20.08 | -20.91 | -53.99 | -66.88 | -72.37 | -99.47 | -67.07 | -5.62 | -529.00 | -0.68 | ||||
| Net Income | -64 | -76 | -82 | -95 | -98 | -98 | -95 | -78 | -92 | -72 | -1 | 12 | 34 | 24 | -28 | -30 | -19 | -8 | -9 | -9 |
| Change (%) | 19.90 | 7.49 | 15.97 | 2.90 | 0.04 | -2.39 | -18.25 | 18.35 | -22.36 | -98.74 | -1,385.78 | 191.48 | -29.10 | -216.53 | 8.27 | -36.30 | -56.98 | 6.32 | 5.94 | |
| % of Revenue | -142.81 | -118.36 | -97.62 | -112.40 | -114.75 | -113.98 | -121.87 | -103.82 | -129.88 | -115.97 | -1.72 | 32.37 | 179.79 | 366.25 | -660.87 | -813.97 | -327.17 | -102.80 | -99.93 | -97.52 |
Source: Capital IQ
